Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Here’s Why Snap Is Moving

Snap Inc (NYSE: SNAP) shares are trading higher by 2.79% to $11.44 Tuesday afternoon. Traders and investors are watching for the company's fourth-quarter earnings announcement, confirmed for after the market close.
byHenry Khederian
January 31, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Snap Inc (NYSE:SNAP) shares are trading higher by 2.79% to $11.44 Tuesday afternoon. Traders and investors are watching for the company’s fourth-quarter earnings announcement, confirmed for after the market close.

According to analyst consensus estimates, Snap is expected to report revenue of $1.3 billion on EPS of 11 cents.

According to Benzinga Pro data, during the third-quarter, Snap posted sales of $1.13 billion. Earnings were up 14.82%, but Snap still reported an overall loss of $359.50 million.

See Also: If You Had $1,000 Right Now, Would You Buy Shiba Inu Or Dogecoin? Over 60% Choose…

Snap Inc has a 52-week high of $41.97 and a 52-week low of $7.33.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Melinta Therapeutics & Cidara Therapeutics Announce Publication Of Pooled Data From Phase 3 Pivotal ReSTORE Trial & Phase 2 STRIVE Trial Of REZZAYO For The Treatment Of Candidemia & Invasive Candidiasis In The Lancet ID

By Benzinga Newsdesk
December 5, 10:08 AM
Publication reaffirms the proven efficacy and safety of rezafungin dosed once-weekly versus a current standard of care echinocandin dosed once-dailyMelinta Therapeutics, LLC and Cidara Therapeutics, Inc. (NASDAQ:CDTX)

CDTX